Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.

Autor: Ribeuz HL; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Willer AS; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Chevalier B; Paris Cité University, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris, France., Sancho M; Department of Physiology and.; Department of Pharmacology, University of Vermont, Burlington, Vermont.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Masson B; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Eyries M; Genetics Department, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France., Jung V; INSERM US24/CNRS UAR3633, Proteomic Platform Necker, Université Paris Cité-Federative Research Structure Necker, Paris, France., Guerrera IC; INSERM US24/CNRS UAR3633, Proteomic Platform Necker, Université Paris Cité-Federative Research Structure Necker, Paris, France., Dutheil M; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Jekmek KE; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Laubry L; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Carpentier G; Gly-CRRET Research Unit 4397, Paris-Est Créteil University, Créteil, France., Perez-Vizcaino F; Department of Pharmacology and Toxicology, Faculty of Medicine, University Complutense of Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.; Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain., Tu L; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Guignabert C; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Chaumais MC; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France.; Paris-Saclay University, Faculty of Pharmacy, Orsay, France.; Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Péchoux C; Paris-Saclay University, INRAE, AgroparisTech, GABI, Jouy-en-Josas, France., Humbert M; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France.; Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Hinzpeter A; Paris Cité University, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris, France., Mercier O; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France.; Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue Hospital, Le Plessis-Robinson, France., Capuano V; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Montani D; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France.; Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Antigny F; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France.

Publikováno v: American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2024 Jul; Vol. 71 (1), pp. 95-109.